GlassScriptPhysician profile
Tapan Patel
NPI 1174919906
$3,140.56
in general payments reported to CMS, 2019-2025
17 companies · $1,035 in 2025
The $1,035 reported for 2025 was more than what a typical Retina Specialist provider received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $37.41 · 2022: $331 · 2023: $903 · 2024: $833 · 2025: $1,035.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,772.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,771.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $793.62 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $783.97 | 2023-2025 | Eylea Hd, Eylea |
| Eyepoint US, INC. | $382.62 | 2022-2023 | |
| Genentech USA, INC. | $221.00 | 2022-2025 | Vabysmo |
| Astellas Pharma US INC | $173.68 | 2023-2025 | Izervay |
| Bausch & Lomb Americas INC. | $171.71 | 2023-2025 | Xipere, Visudyne, Vyzulta |
| Alimera Sciences, INC. | $121.08 | 2023-2024 | Iluvien, Yutiq |
| Coherus Oncology, INC. | $105.71 | 2023 | |
| Ani Pharmaceuticals, INC. | $98.96 | 2024-2025 | Iluvien, Purified Cortrophin Gel |
| Oyster Point Pharma, INC. | $65.56 | 2023-2025 | Tyrvaya |
| Rayner Intraocular Lenses Limited | $50.69 | 2022-2024 | Rayone Emv, Rayone Aspheric, Omidria |
| Amgen INC. | $45.81 | 2024-2025 | Tepezza |
| Alcon Vision LLC | $37.34 | 2021-2025 | Unity |
| Sandoz INC. | $31.28 | 2024 | Cimerli |
| Apellis Pharmaceuticals, INC. | $23.24 | 2024 | Syfovre |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $18.21 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $16.08 | 2025 | Tecnis Iol, Catalys System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tapan Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.